systematic_review
    2019
    High Quality

    Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy

    Unknown authors

    Published in Cochrane Database of Systematic Reviews

    Key Findings

    Sparse, low-certainty evidence on pain reduction with acetyl-L-carnitine; data on function and sensory symptoms lacking.

    Conclusions

    Uncertain whether acetyl-L-carnitine reduces neuropathic pain; safety evidence too uncertain to judge.

    Supplements Studied

    We are very uncertain whether ALC causes a reduction in pain after 6 to 12 months' treatment in people with DPN.

    L-Carnitine
    Amino Acid

    Sparse, low-certainty evidence on pain reduction with acetyl-L-carnitine; data on function and sensory symptoms lacking.

    Related Health Concerns

    Tingling Sensations
    Peripheral Neuropathy

    Study Details

    Year:2019
    Quality Score:9/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.